Acute inflammatory responses are host-protective and normally self-limited; these responses can maintain cell homeostasis and promote defense against various infections and damage factors. However, when improperly managed or inappropriately activated, acute inflammation can lead to persistent and uncontrolled chronic inflammation, which is associated with many other chronic diseases including cardiovascular disease and metabolic disease. Recently, studies have shown that resolution of acute inflammation is a biosynthetically active process. Specialized proresolving lipid mediators (SPMs) known as resolvins and protectins are autacoids that resolve inflammation. A new family of anti-inflammatory and proresolving lipid mediators have recently been reported, known as maresins, which are biosynthesized from docosahexaenoic acid (DHA) by macrophages, have a conjugated double-bond system, and display strong anti-inflammatory and proresolving activity. Here, we review the biological actions, pathways, and mechanisms of maresins, which may play pivotal roles in the resolution of inflammation.
Keyphrases
- oxidative stress
- liver failure
- anti inflammatory
- cardiovascular disease
- fatty acid
- drug induced
- respiratory failure
- type diabetes
- aortic dissection
- photodynamic therapy
- stem cells
- intensive care unit
- metabolic syndrome
- mesenchymal stem cells
- single molecule
- coronary artery disease
- bone marrow
- cardiovascular risk factors
- innate immune